Study of Weekly ALTU-238 Compared With Daily Nutropin AQ in Prepubertal Children With Growth Hormone Deficiency

PHASE2UnknownINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

September 30, 2010

Conditions
Growth Hormone Deficiency
Interventions
DRUG

Somatropin

ALTU-238 0.3 mg/kg daily

DRUG

Somatropin

ALTU-238 0.6 mg/kg daily

DRUG

Somatropin

ALTU-238 0.9 mg/kg daily

DRUG

Somatropin

Nutropin AQ 0.043 mg/kg daily

Trial Locations (11)

11040

RECRUITING

Schneider Children's Hospital, New Hyde Park

32806

RECRUITING

Nemours Children's Clinic, Orlando

45229

RECRUITING

Children's Hospital Medical Centre, Cincinnati

64108

RECRUITING

Children's Mercy Hospital, Kansas City

72202

RECRUITING

Arkansas Children's Hospital, Little Rock

76104

RECRUITING

Cook Children's Hospital, Fort Worth

98105

RECRUITING

Seattle Children's Hospital, Seattle

98122

RECRUITING

Swedish Medical Center, Seattle

01199

RECRUITING

Baystate Medical Centre, Springfield

01655

RECRUITING

UMass Memorial Medical Center, Worcester

07962

RECRUITING

Morristown Memorial Hospital, Morristown

Sponsors
All Listed Sponsors
lead

Altus Pharmaceuticals

INDUSTRY

NCT00837863 - Study of Weekly ALTU-238 Compared With Daily Nutropin AQ in Prepubertal Children With Growth Hormone Deficiency | Biotech Hunter | Biotech Hunter